In this report, Europe Sports Medicine market is projected to reach USD 10,250.5 million by 2024 from USD 5,699.4 million in 2016, at a CAGR of 7.6% in the forecast period 2017 to 2024.
Some of the major factors driving the market for Europe sports medicine market are rising interest in young population for sports, rising awareness of physical and health fitness among the athletes and rising incidence among the health related issues among the individual.
Based on geography, the Europe sports medicine market is segmented into 11 geographical regions, such as,
Germany,
France,
United Kingdom,
Italy,
Spain,
Russia,
Turkey,
Belgium,
Netherlands,
Switzerland and
Rest Of Europe.
Europe sports medicine market competition by top players including -
Arthrex, Inc. is going to dominate the Europe sports medicine market following with Smith & Nephew and DePuy Synthes, along with others such as
Stryker Corporation,
CONMED Corporation,
Johnson & Johnson,
Bird & Cronin, Inc.,
Zimmer Biomet,
Anika Therapeutics,
Ossur, Breg Inc.,
Mueller Sports Medicine, Inc.,
DJO global,
Medtronic.
The Europe sports medicine market is segmented on the basis of product type, body area, end user, and geography.
The Europe sports medicine market is segmented into 4 types, namely orthobiologics, surgical devices, arthroscopy devices, orthopedic braces and supports.
Europe sports medicine market is segmented into knee, hip, shoulder & elbow, foot & ankle and wrist & hand on the basis of body area.
On the basis of procedures, Europe sports medicine market is segmented into knee arthroscopic procedures, hip arthroscopic procedures, shoulder and elbow arthroscopic procedures, foot and ankle arthroscopic procedures, and hand and wrist arthroscopic procedures.
Knee arthroscopic procedure market segment is expected to account for the largest share of 39.3% in Europe sports medicine market.
On the basis of end users, the market is classified into orthopedic clinics, hospitals, ambulatory surgical centers and others.
In 2017, the hospitals segment is expected to dominate the Europe sports medicine market with 65.4% market share. This segment is expected to grow at the highest CAGR of 8.4% in the forecast period 2017 to 2024.
